PL365890A1 - Zastosowanie selektywnych agonistów receptorów dopaminowych D4 w leczeniu dysfunkcji seksualnej - Google Patents

Zastosowanie selektywnych agonistów receptorów dopaminowych D4 w leczeniu dysfunkcji seksualnej

Info

Publication number
PL365890A1
PL365890A1 PL01365890A PL36589001A PL365890A1 PL 365890 A1 PL365890 A1 PL 365890A1 PL 01365890 A PL01365890 A PL 01365890A PL 36589001 A PL36589001 A PL 36589001A PL 365890 A1 PL365890 A1 PL 365890A1
Authority
PL
Poland
Prior art keywords
receptor agonists
sexual dysfunction
treating sexual
selective dopamine
dopamine
Prior art date
Application number
PL01365890A
Other languages
English (en)
Inventor
Jorge D. Brioni
Teodozyj Kolasa
Gin C. Hsieh
Diane L. Donnelly-Roberts
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27109879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL365890(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/985,974 external-priority patent/US20020103105A1/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of PL365890A1 publication Critical patent/PL365890A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL01365890A 2000-11-22 2001-11-21 Zastosowanie selektywnych agonistów receptorów dopaminowych D4 w leczeniu dysfunkcji seksualnej PL365890A1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71831100A 2000-11-22 2000-11-22
US09/985,974 US20020103105A1 (en) 2000-11-22 2001-11-07 Use of selective dopamine D4 receptor agonists for treating sexual dysfunction
PCT/US2001/043139 WO2002041894A2 (en) 2000-11-22 2001-11-21 Selective dopamine d4 receptor agonists for treating sexual dysfunction

Publications (1)

Publication Number Publication Date
PL365890A1 true PL365890A1 (pl) 2005-01-10

Family

ID=27109879

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365890A PL365890A1 (pl) 2000-11-22 2001-11-21 Zastosowanie selektywnych agonistów receptorów dopaminowych D4 w leczeniu dysfunkcji seksualnej

Country Status (24)

Country Link
EP (1) EP1345608B1 (pl)
JP (1) JP2004534725A (pl)
KR (1) KR20030051857A (pl)
CN (1) CN1531434A (pl)
AR (1) AR035600A1 (pl)
AT (1) ATE358483T1 (pl)
AU (2) AU2002226895B2 (pl)
BG (1) BG107810A (pl)
BR (1) BR0110450A (pl)
CA (1) CA2429383A1 (pl)
CZ (1) CZ20031458A3 (pl)
DE (1) DE60127712T2 (pl)
ES (1) ES2284727T3 (pl)
HU (1) HUP0402358A3 (pl)
IL (1) IL155094A0 (pl)
MX (1) MXPA03004547A (pl)
NO (1) NO20032304L (pl)
NZ (1) NZ525086A (pl)
PE (1) PE20020557A1 (pl)
PL (1) PL365890A1 (pl)
SK (1) SK7242003A3 (pl)
TW (1) TWI293254B (pl)
UY (1) UY27031A1 (pl)
WO (1) WO2002041894A2 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
MXPA04011621A (es) * 2002-05-23 2005-03-31 Abbott Lab Acetamidas y benzamidas que son utiles en el tratamiento de disfuncion sexual.
PL1912650T3 (pl) 2005-08-03 2018-01-31 Sprout Pharmaceuticals Inc Zastosowanie flibanseryny w leczeniu otyłości
EP1945214A1 (en) 2005-10-29 2008-07-23 Boehringer Ingelheim International GmbH Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
EP2037927B1 (en) 2006-06-30 2010-01-27 Boehringer Ingelheim International GmbH Flibanserin for the treatment of urinary incontinence and related diseases
EP2054041A2 (en) 2006-08-14 2009-05-06 Boehringer Ingelheim International GmbH Formulations of flibanserin and method for manufacturing the same
CN101505736A (zh) 2006-08-25 2009-08-12 贝林格尔.英格海姆国际有限公司 控制释放系统及其制造方法
UY31335A1 (es) 2007-09-12 2009-04-30 Tratamiento de sintomas vasomotores
CA2832822A1 (en) * 2011-04-10 2012-10-18 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970704698A (ko) * 1994-08-05 1997-09-06 스피겔 알렌 제이 도파민 작용 활성을 갖는 벤즈이미다졸 유도체(benzimidazole derivatives having dopaminergic activity)
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
EP0982030A3 (en) * 1998-08-17 2000-05-10 Pfizer Products Inc. 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
US6291471B1 (en) * 1998-12-17 2001-09-18 Abb Holdings, Inc. Use of apomorphine for the treatment of organic erectile dysfunction in males

Also Published As

Publication number Publication date
CA2429383A1 (en) 2002-05-30
IL155094A0 (en) 2003-10-31
ES2284727T3 (es) 2007-11-16
ATE358483T1 (de) 2007-04-15
WO2002041894A3 (en) 2002-10-17
JP2004534725A (ja) 2004-11-18
AU2002226895B2 (en) 2006-10-12
MXPA03004547A (es) 2004-03-26
HUP0402358A3 (en) 2009-08-28
DE60127712D1 (de) 2007-05-16
NO20032304L (no) 2003-07-15
AU2689502A (en) 2002-06-03
DE60127712T2 (de) 2007-12-27
BG107810A (bg) 2004-02-27
HK1059884A1 (en) 2004-07-23
HUP0402358A2 (hu) 2005-03-29
UY27031A1 (es) 2002-07-31
EP1345608B1 (en) 2007-04-04
KR20030051857A (ko) 2003-06-25
WO2002041894A2 (en) 2002-05-30
CZ20031458A3 (cs) 2004-02-18
CN1531434A (zh) 2004-09-22
NO20032304D0 (no) 2003-05-21
EP1345608A2 (en) 2003-09-24
TWI293254B (en) 2008-02-11
SK7242003A3 (en) 2004-01-08
NZ525086A (en) 2006-07-28
PE20020557A1 (es) 2002-06-25
BR0110450A (pt) 2005-02-09
AR035600A1 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
EE200300246A (et) EP4 retseptori suhtes selektiivsed agonistid osteoporoosi raviks
HUP0201184A3 (en) Use of selective antagonists of the alpha1b-adrenergic receptor for improvement of sexual dysfunction
ZA200501308B (en) Agonism of the 5HT2a receptor for treatment of thermoregulatory dysfunction
IS6388A (is) EP4 viðtaka valvís gerandefni í meðhöndluninni á beingisnun
IS2494B (is) Notkun á morfólínóli til meðhöndlunar á kynferðislegri vanvirkni
IL153915A0 (en) Use of dopamine d2/d3 receptor agonists to treat fibromyalgia
HUP0202253A3 (en) Selective iglur5 receptor antagonists for the treatment of migraine
HUP0202687A3 (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
EP1121939A3 (en) Treatment of osteoporosis with EP2/EP4 receptor selective agonists
AU2689502A (en) The use of selective dopamine d4 receptor agonists for treating sexual dysfunction
PL370842A1 (pl) Selektywni agoniści receptora dopaminowego D3 do leczenia dysfunkcji seksualnej
AP2005003325A0 (en) Morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction
IL154215A0 (en) Medicine for fighting against sexual dysfunction
PL362980A1 (pl) Sposób leczenia dysfunkcji seksualnej
IL149266A0 (en) Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension
MY155220A (en) Selective dopamine d4 receptor agonists for treating sexual dysfunction
GB0011926D0 (en) Treatment of sexual dysfunction
AU2002314319A1 (en) Use of adenosine a1 receptor agonists for the treatment of nociceptive pain
ZA200006376B (en) Compounds for the treatment of female sexual dysfunction.

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)